(Q37889165)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Induced pluripotent stem cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

main subject

regenerative medicine

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Neeraj Satija

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Rajendra Prashad Tripathi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Gurudutta U Gangenahalli

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

1 reference

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

Stem Cell Reviews and Reports

4 February 2020

published in

1 reference

24 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

100-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Establishment in culture of pluripotential cells from mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Human embryos derived by somatic cell nuclear transfer using an alternative enucleation approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Somatic cell nuclear transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Changing potency by spontaneous fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Comparative study of different procedures for the collection and banking of umbilical cord blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Methods of isolation and cryopreservation of stem cells from cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Human embryonic stem cells possess immune-privileged properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of induced pluripotent stem cell lines from Tibetan miniature pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of human induced pluripotent stem cells from dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Reprogramming of pancreatic beta cells into induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Direct reprogramming of human neural stem cells by OCT4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of pluripotent stem cells from adult mouse liver and stomach cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Guidelines and techniques for the generation of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

A drug-inducible system for direct reprogramming of human somatic cells to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induced pluripotent stem cell generation using a single lentiviral stem cell cassette

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induced pluripotent stem cells generated without viral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induced pluripotent stem cells free of exogenous reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Vitamin C enhances the generation of mouse and human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

c-Myc is dispensable for direct reprogramming of mouse fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA-binding activity requires the POU-specific domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Transcriptional regulation of human Oct4 by steroidogenic factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Regulation of embryonic stem cell self-renewal and pluripotency by Foxd3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Tcf3 functions as a steady-state limiter of transcriptional programs of mouse embryonic stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Sox genes find their feet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Multipotent cell lineages in early mouse development depend on SOX2 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

SOX2 functions to maintain neural progenitor identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Sox2 is required for sensory organ development in the mammalian inner ear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Nanog binds to Smad1 and blocks bone morphogenetic protein-induced differentiation of embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Transcriptional regulation of nanog by OCT4 and SOX2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The Grb2/Mek pathway represses Nanog in murine embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Klf4 reverts developmentally programmed restriction of ground state pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

KLF4α Up-regulation Promotes Cell Cycle Progression and Reduces Survival Time of Patients With Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

c-Myc is required for maintenance of glioma cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Coordinated control of self-renewal and differentiation of neural stem cells by Myc and the p19ARF-p53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Myc-regulated microRNAs attenuate embryonic stem cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Core transcriptional regulatory circuitry in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Wnt signaling promotes reprogramming of somatic cells to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Oct-3/4 regulates stem cell identity and cell fate decisions by modulating Wnt/β-catenin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Decision making by p53: life, death and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Mediation of c-Myc-induced apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Suppression of induced pluripotent stem cell generation by the p53-p21 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The Ink4/Arf locus is a barrier for iPS cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Senescence impairs successful reprogramming to pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Reprogramming towards pluripotency requires AID-dependent DNA demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Female human iPSCs retain an inactive X chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Embryonic stem cell-specific MicroRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Embryonic stem cell-specific microRNAs promote induced pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Human embryonic stem cells express a unique set of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

MicroRNA profiling of human-induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Disease-specific induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Variation in the safety of induced pluripotent stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

A chemical platform for improved induction of human iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of induced pluripotent stem cells in the absence of drug selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Broader Implications of Defining Standards for the Pluripotency of iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

The Nuclear Receptor Nr5a2 Can Replace Oct4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-011-9279-X

Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia

21 January 2018

1 reference

12 December 2020

Generation of induced pluripotent stem cell lines from adult rat cells

1 reference

12 December 2020

Producing primate embryonic stem cells by somatic cell nuclear transfer.

1 reference

12 December 2020

First patient enters trial to test safety of stem cells in spinal injury

1 reference

12 December 2020

Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells

1 reference

12 December 2020

Alternative induced pluripotent stem cell characterization criteria for in vitro applications

1 reference

12 December 2020

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome

1 reference

12 December 2020

Umbilical cord blood banking for unrelated transplantation: evaluation of cell separation and storage methods

1 reference

12 December 2020

Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology

1 reference

12 December 2020

The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells

1 reference

12 December 2020

Autologous bone-marrow stem cells for myocardial infarction

1 reference

12 December 2020

Generation of induced pluripotent stem cells using recombinant proteins

1 reference

12 December 2020

Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.

1 reference

12 December 2020

BMP4 initiates human embryonic stem cell differentiation to trophoblast

1 reference

12 December 2020

Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2.

1 reference

12 December 2020

Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury.

1 reference

12 December 2020

A combined chemical and genetic approach for the generation of induced pluripotent stem cells

1 reference

12 December 2020

10.1007/S12015-011-9279-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671061%20AND%20SRC:MED&resulttype=core&format=json